Non-Antibody Products — page 64 of 94
Non-Antibody Products
Page 64 of 94
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Lipid AX4 | of mRNA in vivo; administration of LNPs containing lipid AX4 and encapsul… | 10 mg | 39070-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid AX4 | of mRNA in vivo; administration of LNPs containing lipid AX4 and encapsul… | 25 mg | 39070-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid AX4 | of mRNA in vivo; administration of LNPs containing lipid AX4 and encapsul… | 50 mg | 39070-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2019-nCoV Spike Protein S1 (T19R, G142D, del157-158, L452R, T478K, D614G, P681R) | 2019-nCoV Spike Protein S1 (T19R, G142D, del157-158, L452R, T478K… | 100 ug, 50 ug, 20 ug, 10 ug | orb1742923 |
 BIORBYT LTD. |
More Info |
| 2019-nCoV Spike Protein S1 (T19R, ?157-158, L452R, T478K, D614G, P681R) | 2019-nCoV Spike Protein S1 (T19R, ?157-158, L452R, T478K, D614G,… | 100 ug, 50 ug, 20 ug, 10 ug | orb1742937 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (2019-nCoV) Spike S1 (K417N, E484K, N501Y, D614G)-His Recombinant Protein | Purity 98.00%. MW: approxiamtely 76.4 kDa | 100 ug | orb1953843 |
BIORBYT LTD. |
More Info |
| Guinea Pig Anti-SARS-CoV-2 (Covid-19) IgG Antibody To Spike RBD Protein Quantitative ELISA | The method employs indirect sandwich ELISA technique. SARS-CoV-| 96 wells |
KBVH015-42 |
|
 EAGLE BIOSCIENCES INC.
More Info
|
|
| SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike P681H Peptide | SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike… | 0.05 mg | orb1231664 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike… | 50 ug | orb1231044 |
BIORBYT LTD. |
More Info |
| Mouse Anti-SARS-CoV-2 (Covid-19) IgG2b Antibody To Whole Spike Protein Quantitative ELISA | The method employs indirect sandwich ELISA technique. SARS-CoV-| 96 wells |
KBVH015-55 |
|
EAGLE BIOSCIENCES INC.
More Info
|
|
| SARS-CoV-2 (B.1.1.7 + E484K) Spike S1+S2 trimer Protein (His) | Purity 98.00%. MW: approxiamtely 136.05 kDa | 100 ug | orb1953492 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 BF.7/BA.5.2.6/BF.11 Omicron Variant Recombinant Spike Trimer His Tag | n/a | 20 ul | orb1945936 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain L452R, T478K variant (rabbit IgG1 Fc-tagged) | Source: Active recombinant C-terminal rabbit IgG1 Fc-tagged SARS-CoV
| 100 µg |
34837-100 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| GK241 | µM; inhibits SARS-CoV-2 Mpro (IC50 = 24 µM) | 1 mg | 37689-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GK241 | µM; inhibits SARS-CoV-2 Mpro (IC50 = 24 µM) | 10 mg | 37689-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GK241 | µM; inhibits SARS-CoV-2 Mpro (IC50 = 24 µM) | 5 mg | 37689-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike… | 50 ug | orb1231047 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (2019-nCoV) Spike S1 NTD (L18F, D80A, D215G, LAL242-244 deletion, R246I) Protein (His | A DNA sequence encoding the SARS-CoV-2 (2019-nCoV
| 100µg |
40591-V08H13 |
|
 SINO BIOLOGICAL, INC.
More Info
|
|
| SARS-CoV-2 (COVID-19) Spike Q493R G496S Q498R N501Y Y505H Peptide (Omicron) | SARS-CoV-2 (COVID-19) Spike Q493R G496S Q498R N501Y Y505… | 0.05 mg | orb1231628 |
BIORBYT LTD. |
More Info |
| Biotinylated SARS-CoV-2 Spike RBD Protein (L452R, T478K), His, Avitag™ (Trehalose free) (MALS | Biotinylated SARS-CoV-2 Spike RBD (L452R, T478K), His, A… | 25ug | SPD-C82Ep-25ug |
 ACROBIOSYSTEMS USA |
More Info |
| Biotinylated SARS-CoV-2 Spike RBD Protein (L452R, T478K), His, Avitag™ (Trehalose free) (MALS | Biotinylated SARS-CoV-2 Spike RBD (L452R, T478K), His, A… | 200ug | SPD-C82Ep-200ug |
ACROBIOSYSTEMS USA |
More Info |
| SARS-CoV-2 Spike S1+S2 (E484K, F565L, D614G, V1176F) Protein (His) | Purity 98.00%. MW: approxiamtely 134.35 kDa | 100 ug | orb1953544 |
BIORBYT LTD. |
More Info |
| Lipid 331 | -2 spike glycoprotein with mouse complement C3d increase serum an… | 1 mg | 39771-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 331 | -2 spike glycoprotein with mouse complement C3d increase serum an… | 10 mg | 39771-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 331 | -2 spike glycoprotein with mouse complement C3d increase serum an… | 5 mg | 39771-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 2019-nCoV Spike Protein S1 (K417N, E484K, N501Y, D614G) | 2019-nCoV Spike Protein S1 (K417N, E484K, N501Y, D614G) | 100 ug, 50 ug, 20 ug, 10 ug | orb1742927 |
BIORBYT LTD. |
More Info |
| 2019-nCoV Spike Protein S1 (?69-70 ?144 N501Y A570D D614G P681H) | 2019-nCoV Spike Protein S1 (?69-70 ?144 N501Y A570D D614G P681H).… | 100 ug, 50 ug, 20 ug, 10 ug | orb1742935 |
BIORBYT LTD. |
More Info |
| Human SARS-CoV-2 Spike RBD Neutralization Antibody (E484Q + L452R Mutation Ab) ELISA Kit | Human SARS-CoV-2 Spike RBD Neutralization Antibody (E484… | 96 tests, | abx395201 |
 ABBEXA LTD |
More Info |
| SARS-CoV-2 (B.1.1.7 + E484K) Spike S1+S2 trimer Protein (ECD, His tag) (HPLC-verified) | A DNA sequence encoding the SARS-CoV-2 Spike S1+S2
| 100µg |
40589-V08H17 |
|
SINO BIOLOGICAL, INC.
More Info
|
|
| SARS-CoV-2 Spike S1+S2 ECD (HV69-70 deletion, D614G, D796H) Insect Cell Lysate | Baculovirus-Insect Cell SARS-CoV-2 Spike S1+S2… | 300µg | 40589-V08B5L |
SINO BIOLOGICAL, INC. |
More Info |
| SARS-CoV-2 Spike S1+S2 (YH145-146 deletion, E484K, D614G) Protein (ECD, His Tag) | A DNA sequence encoding the SARS-CoV-2 Spike S1+S2
| 100µg |
40589-V08B14 |
|
SINO BIOLOGICAL, INC.
More Info
|
|
| GRL-0496 | An inhibitor of SARS-CoV and SARS-CoV-2 Mpro (I… | 1 mg | 36114-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GRL-0496 | An inhibitor of SARS-CoV and SARS-CoV-2 Mpro (I… | 10 mg | 36114-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| GRL-0496 | An inhibitor of SARS-CoV and SARS-CoV-2 Mpro (I… | 5 mg | 36114-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SARS-CoV-2 (Omicron B.1.1.529) Spike RBD (F375S, A484E), Fc Tag | SARS-CoV-2 (Omicron B.1.1.529) Spike RBD (F375S, A484E),… | 1 mg, 100 ug, 50 ug | orb1805243 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain K417N, E484K, N501Y variant (rabbit IgG1 Fc-tagged) | Source: Active recombinant C-terminal rabbit IgG1 Fc-tagged SARS-CoV
| 100 µg |
33868-100 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| MutaPLEX® RespiraScreen 2 DIFF, RT-PCR | of Influenza Virus A (Flu A), Influenza Virus B (Flu B) from the pandemic… | 96 tests | KG192896 |
 IMMUNDIAGNOSTIK AG |
More Info |
| L202 | encapsulating nucleoside-modified mRNA encoding pre-fusion stabilized SAR… | 1 mg | 37841-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| L202 | encapsulating nucleoside-modified mRNA encoding pre-fusion stabilized SAR… | 10 mg | 37841-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| L202 | encapsulating nucleoside-modified mRNA encoding pre-fusion stabilized SAR… | 5 mg | 37841-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Human Anti-SARS-CoV-2 (Covid-19) IgG Antibody to spike protein S2 Quantitative TITRA- TION ELISA | The method employs indirect sandwich ELISA technique. SARS-CoV-| 12 x 8 wells |
KBVH015-29 |
|
EAGLE BIOSCIENCES INC.
More Info
|
|
| SARS-CoV-2 XBB.1.16 (Omicron) Spike S1+S2 trimer Protein (ECD, His Tag) (HPLC-verified) | Purity 98.00%. MW: approxiamtely 136.74 kDa | 100 ug | orb1953114 |
BIORBYT LTD. |
More Info |
| Mouse Anti-SARS-CoV-2 (Covid-19) IgG1 Antibody To Whole Spike Protein Quantitative Titration ELISA | The method employs indirect sandwich ELISA technique. SARS-CoV-| 96 wells |
KBVH015-53 |
|
EAGLE BIOSCIENCES INC.
More Info
|
|
| SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein | SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y)… | 0.1 mg | orb1231553 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y) Recombinant Protein | SARS-CoV-2 (COVID-19) UK variant (B.1.1.7) S RBD (N501Y)… | 0.1 mg | orb1231548 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (A119S, R203K, G204R, M234I) Protein (His) | Purity 98.00%. MW: approxiamtely 46.7 kDa | 100 ug | orb1953735 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (D63G, R203M, G215C, D377Y) Protein (His) | Purity 98.00%. MW: approxiamtely 46.60 kDa | 100 ug | orb1953635 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (P13L, R203K, G204R, G214C) Protein (His) | Purity 98.00%. MW: approxiamtely 46.73 kDa | 100 ug | orb1953636 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Nucleocapsid (P13L, R203K, G204R, Q384H) Protein (His) | Purity 98.00%. MW: approxiamtely 46.69 kDa | 100 ug | orb1953516 |
BIORBYT LTD. |
More Info |
| SARS-CoV-2 Spike RBD (E484K, K417T, N501Y) Protein (His & Avi), Biotinylated | Purity 98.00%. MW: approxiamtely 28.49 kDa | 20 ug | orb1953673 |
BIORBYT LTD. |
More Info |